期刊文献+

As_2O_3对消化道肿瘤的VEGF、nm23表达的影响 被引量:2

Effect of As_2O_3 on gastrointestinal cancer expression of nm23 and VEGF
下载PDF
导出
摘要 目的通过观察消化道肿瘤术前短时间、小剂量三氧化二砷(As2O3)应用,探讨As2O3对消化道肿瘤的VEGF、nm23表达的影响。方法分别在手术前给8例确诊为消化道肿瘤的患者As2O3治疗3天。在用药前内镜下和手术中提取患者的病理组织。利用免疫组织化学法检测6例胃癌和2例肠癌组织中的VEGF、nm23表达情况。结果应用As2O3注射液化疗后与用药前比较,肿瘤组织中VEGF表达下调,nm23表达上调。结论体内实验证实,As2O3可以通过下调VEGF及上调nm23抑制肿瘤的浸润与转移。 Objective Through the short preoperative observation of gastrointestinal cancer,and the expression changes of VEGF and nm23 by using low-dose As2O3,this experiment discuss the efficacy of chemotherapy by using As2O3.Methods 8 patients diagnosed as gastrointestinal cancer were given As2O3 treatment respectively for three days before surgery.Pathological tissues were extracted at pre-administration and during the operation.By using immunohistochemistry methods,expression changes of VEGF and nm23 were detected in gastrointestinal cancer tissues in 8 patients.Results VEGF expression showed down-regulation,and nm23 expressin up-regulation.Conclusion In vivo tests confirm that As2O3′s antitumor effectis related to down-regulation of VEGF and up-regulation of nm23.It inhibits the tumor′s infiltration and metastasis.
出处 《实用临床医药杂志》 CAS 2010年第9期11-14,共4页 Journal of Clinical Medicine in Practice
关键词 三氧化二砷(As2O3) 消化道肿瘤 VEGF NM23 arsenic trioxide(As2O3) gastrointestinal cancer VEGF nm23
  • 相关文献

参考文献12

二级参考文献11

共引文献81

同被引文献19

  • 1冯众一,谭文翔.COX-2及其抑制剂与消化道肿瘤[J].中华肝胆外科杂志,2006,12(4):282-283. 被引量:1
  • 2张惠,陈卫昌,岑建农.三氧化二砷对人大肠癌LoVo细胞血管内皮生长因子表达的影响[J].江苏医药,2007,33(2):153-155. 被引量:5
  • 3白玉贤,易继林,隋红.三氧化二砷对人大肠癌ls174细胞凋亡及相关耐药蛋白基因表达的影响[J].中国肿瘤临床,2007,34(10):574-576. 被引量:6
  • 4Walker DK, Held - Warmkessel J. Acute promyelocytic leukemia : an overview with implications for oncology nurses [ J ]. Clin J On- col Nurs, 2010,14(6) :747 -759.
  • 5Beauehamp EM, Ringer L, Bulut G. Arsenic trioxide inhibits hu-man cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway[ J]. Clin Invest, 2011,121 ( 1 ) : 148 - 160.
  • 6Tomuleasa C, Soritau O, Fischer - Fodor E. Arsenic trioxide plus cisplatin/interferon a -2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma [ J]. He- matol Oncol Stem Cell Ther, 2011,2(4) : 60 -66.
  • 7Alimoghaddam K, Shariftabrizi A, Tavangar M, et al. Anti - leu- kemic and anti - angiogenesis efficacy of arsenic trioxide in new cases of acute promyelocytic leukemia [ J ]. Leuk Lymphoma, 2006,47(1) : 81 -88.
  • 8Litzow MR. Arsenic trioxide [ J ]. Expert Opin Pharmacother, 2008,9(10) :1773 - 1785.
  • 9Gong W, Wang L, Yao JC, et al. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer [ J ]. Clin Cancer Res, 2005,11 (4) :1386 - 1393.
  • 10Li HM, Long Y, Qing C, et al. Arsenic trioxide induces apopto- sis of Burkitt lymphoma cell lines through multiple apoptotic path- ways and triggers antiangiogenesis [ J]. Oncol Res, 2011 , 19 ( 3 -4) :149- 163.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部